Skip Navigation

COVID-19 Update

We are vaccinating patients ages 12+. Learn more:

Vaccines | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker |  Email Alerts

Jennifer Yeong-Shin Sheng, M.D.

Headshot of Jennifer Yeong-Shin Sheng
  • Assistant Professor of Oncology

Languages: English, Mandarin


Hematology Oncology, Oncology


The Johns Hopkins Hospital

600 N. Wolfe Street
Baltimore, MD 21287 map
Phone: 410-614-0682


Dr. Jenni Sheng is an Assistant Professor in the Department of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include internal medicine and oncology. Caring for men and women with cancer, she addresses living with, through and beyond cancer. As she primarily treat patients with breast cancer, she discusses the best treatment options, manages symptoms from the cancer and treatment-related side effects and focuses on psychosocial aspects of care. In keeping with comprehensive survivorship care, she plans surveillance and screening and encourages health promotion (diet, exercise and interpersonal relationships) and care coordination. more


  • Assistant Professor of Oncology

Departments / Divisions

  • Oncology - Division of Women's Malignancies



  • MD; UMDNJ-New Jersey Medical School (2013)


  • Internal Medicine; Temple University Medical Center (2016)


  • Medical Oncology; Johns Hopkins University School of Medicine (2019)

Research & Publications

Research Summary

Dr. Sheng's research focuses on addressing the needs of breast cancer patients, especially improving quality of life and addressing comorbidity, promptly detecting sequela of endocrine therapy, determining the optimal population for and timing of survivorship care and furthering obesity management in breast cancer patients. 

Selected Publications

Sheng JY, Blackford AL, Bardia A, Venkat R, Rosson G, Giles J, Hayes DF, Jeter SC, Zhang Z, Hayden J, Nguyen A, Storniolo AM, Tarpinian K, Henry NL, Stearns V. Prospective evaluation of finger two-point discrimination and carpal tunnel syndrome among women with breast cancer receiving adjuvant aromatase inhibitor therapy. Breast Cancer Res Treat. 2019 Aug; 176(3): 617-624. PMID: 31079282.

Skuli SJ, Sheng JY, Bantug ET, Zafman N, Riley C, Ruck JM, Smith KC, Snyder CF, Smith KL, Stearns V, Wolff AC. Survivorship care visits in a high-risk population of breast cancer survivors. Breast Cancer Res Treat. 2019 Feb; 173(3):701-708. 2019 Feb; 173(3): 701-708. PubMed PMID: 30406364.

Sheng JY, Sharma D, Jerome GJ, Santa-Maria CA. Obese Breast Cancer Patients and Survivors: Management Consideration. Oncology. 2018; 32 (8): 410-7. PMID: 30153321

Sheng JY, Santa-Maria CA, Mangini N, Norman H, Couzi R, Nunes R, Wilkinson M, Visvanathan K, Connolly RM, Roussos-Torres ET, Fetting JH, Armstrong DK, Tao JJ, Jacobs L, Wright JL, Thorner ED, Hodgdon C, Horn S, Wolff AC, Stearns V, and Smith KL. Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach. JCO Oncology Practice. 2020 Jun 30; OP2000364. PMID: 32603252.

Activities & Honors


  • Conquer Cancer Foundation Young Investigator Award, Breast Cancer Research Foundation Cure, 2019

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 


Is this you? Edit Profile
back to top button